Aastrom Biosciences Financial Market Data
| Last Close 12-Sep-2008 |
$0.28 |
Price/ Sales Ratio |
81.45 |
| 52-Week High |
$1.43 |
Price/ Book Ratio |
1.82 |
| 52-Week Low |
$0.27 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
0.0 |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$37.2 |
Return on Assets |
(68.2%) |
| Shares Outstanding (mil.) |
132.9 |
Return on Equity |
(78.1%) |
| Dividend Rate |
-- |
Current Ratio |
11.46 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
0.05 |
| # of Institutional Holders |
39 |
% Owned by Institutions |
5.0% |
| Latest Short Interest Ratio |
-- |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
(23.8%) |
(42.6%) |
(38.2%) |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
